Dual-Diagnosis and Compulsory Treatment

• ClinicalTrials.gov Identifier: NCT00970372
• Recruitment Status: Completed
• First Posted: September 2, 2009
• Last Update Posted: April 16, 2014
• Sponsor: Sorlandet Hospital HF
• Information provided by (Responsible Party): Sorlandet Hospital HF

Study Description

Brief Summary:

The Norwegian Social and Welfare Act of 1992, opened for compulsory commitment of patients with serious alcohol and drug problems to inpatient care. Clinical research of compulsory committed dual diagnosed patients is to date unavailable and is demanded by the health authorities of Norway. Because there has been limited examination/screening and no post-treatment research efforts on this group of patients, the investigators have limited knowledge of the treatment as well as the patient group. Do compulsory treated patients differ from those voluntarily admitted? Does this type of treatment influence the patients' motivation to change their behaviour, and does the treatment effort lead to positive outcome effects in the long run?

The primary aim is to acquire new and in depth descriptive knowledge about the compulsory treated group of patients according to: Drug dependence, psychiatric and somatic co-morbidity and socio-demographic characteristics, and investigate whether the treatment yields the intended outcomes in terms of improved substance abuse measures.

A second aim is to compare the group with a corresponding group of voluntarily admitted patients within the same wards. A follow-up interview focusing on motivational issues within 6 months post treatment to evaluate the long-term results of the treatment is planned.

A quasi-experimental, prospective case-control study will be conducted. Compulsory committed patients in five counties during a two year period, will be compared to a group of voluntarily admitted patients. The groups will be compared regarding 1) description and screening 2) motivation to change and 3) outcome results after 6 months.

Both official authorities as well as clinical practitioners would benefit from valid Norwegian results and knowledge within this field to form further policies and evidence based best practice for this vulnerable group of patients.

Condition or disease
Substance-Related Disorders; Dual Diagnosis

Study Design

• Study Type: Observational
• Actual Enrollment: 202 participants
• Time Perspective: Prospective
• Official Title: Compulsory Treatment of Alcohol and Drug Dependent Patients and Dual Diagnosis in 5 Counties of Health Region South-East, Norway
• Study Start Date: September 2008
• Actual Primary Completion Date: May 2012
• Actual Study Completion Date: May 2012

Groups and Cohorts

Group/Cohort
Involuntary patients; Compulsory treated patients according to the Norwegian Social and Welfare Act of 1992. Most patients have dualdiagnosis.
Voluntary patients; Voluntary patients on the same wards. Most patients have dual-diagnosis.

Outcome Measures

Primary Outcome Measures :

1. Substance use outcomes measured by Europ-ASI Quality of Life [ Time Frame: 6 months after discharge ]

Secondary Outcome Measures :

1. Psychological distress (SCL-90-R) [ Time Frame: 6 months after discharge ]

Eligibility Criteria

• Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No
• Sampling Method: Non-Probability Sample

Study Population

In five counties there are a total of eight beds reserved for compulsory treatment according to the LOST § 6.2 regulation. Of these, four are situated at the Addiction Unit at Sørlandet Hospital (Kristiansand) and four at the Vestfold Clinic, part of the psychiatric section in the county of Vestfold, Tønsberg. It will be necessary to include both sites for two years of inclusion in this study to obtain sufficient samples, as there are only approximately 35 patients in the compulsory committed category annually in this region. All eligible patients compulsory committed to the two wards in Kristiansand and Tønsberg during a twenty-four month period will be asked to participate during their initial assessment.

Criteria

Inclusion Criteria:

• Patients with alcohol and substance use disorders
• Estimated premorbid IQ of 70 or higher

Exclusion Criteria:

• Active drug or alcohol abuse

Contacts and Locations

Locations

Norway

Sorlandet Hospital

Kristiansand, Vest Agder, Norway, 4604

Sponsors and Collaborators

Sorlandet Hospital HF

Investigators

• Study Director: Øistein Kristensen; Sørlandet Sykehus HF

More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Opsal A, Kristensen Ø, Clausen T. Readiness to change among involuntarily and voluntarily admitted patients with substance use disorders. Subst Abuse Treat Prev Policy. 2019 Nov 6;14(1):47. doi: 10.1186/s13011-019-0237-y.

Pasareanu AR, Vederhus JK, Opsal A, Kristensen Ø, Clausen T. Mental distress following inpatient substance use treatment, modified by substance use; comparing voluntary and compulsory admissions. BMC Health Serv Res. 2017 Jan 3;17(1):5. doi: 10.1186/s12913-016-1936-y.

• Responsible Party: Sorlandet Hospital HF
• ClinicalTrials.gov Identifier: NCT00970372
• Other Study ID Numbers: SSHF_815360
• First Posted: September 2, 2009
• Last Update Posted: April 16, 2014
• Last Verified: April 2014

Keywords provided by Sorlandet Hospital HF:

Coercion

Additional relevant MeSH terms:

Disease; Substance-Related Disorders; Pathologic Processes; Chemically-Induced Disorders; Mental Disorders